| Basics |
Omnicell, Inc.
Omnicell Inc provides automation and business analytics software solutions for patient-centric medication and supplies management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing.
|
| IPO Date: |
August 7, 2001 |
| Sector: |
Healthcare |
| Industry: |
Health Care Technology |
| Market Cap: |
$1.42B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.62 | 1.68%
|
| Avg Daily Range (30 D): |
$0.52 | 1.67%
|
| Avg Daily Range (90 D): |
$0.46 | 1.49%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.29M |
| Avg Daily Volume (30 D): |
.28M |
| Avg Daily Volume (90 D): |
.35M |
| Trade Size |
| Avg Trade Size (Sh.): |
86 |
| Avg Trade Size (Sh.) (30 D): |
39 |
| Avg Trade Size (Sh.) (90 D): |
40 |
| Institutional Trades |
| Total Inst.Trades: |
6,050 |
| Avg Inst. Trade: |
$2.63M |
| Avg Inst. Trade (30 D): |
$2.57M |
| Avg Inst. Trade (90 D): |
$2.27M |
| Avg Inst. Trade Volume: |
.05M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.34M |
| Avg Closing Trade (30 D): |
$2.64M |
| Avg Closing Trade (90 D): |
$2.73M |
| Avg Closing Volume: |
54.12K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$.5
|
$.12
|
$-.15
|
|
Diluted EPS
|
$.5
|
$.12
|
$-.15
|
|
Revenue
|
$ 1.15B
|
$ 290.56M
|
$ 269.67M
|
|
Gross Profit
|
$ 502.64M
|
$ 127.68M
|
$ 110.94M
|
|
Net Income / Loss
|
$ 23.09M
|
$ 5.64M
|
$ -7.02M
|
|
Operating Income / Loss
|
$ 15.46M
|
$ 8.12M
|
$ -11.62M
|
|
Cost of Revenue
|
$ 646.89M
|
$ 162.88M
|
$ 158.73M
|
|
Net Cash Flow
|
$ -146.74M
|
$ 17.1M
|
$ 15.79M
|
|
PE Ratio
|
0.00
|
|
|
|
|
|
